secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001558370-25-000907
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

IRADIMED Q4 revenue $19.4M (+11% YoY); raises quarterly dividend to $0.17/share
-------------------------------------------------------------------------------

- Q4 revenue record $19.4M (+11% YoY); GAAP EPS $0.40, non-GAAP EPS $0.44.
- Full year 2024 revenue $73.2M (+12% YoY); GAAP EPS $1.50, non-GAAP EPS $1.66.
- Quarterly dividend increased 13% to $0.17/share from $0.15; payable March 5, 2025.
- FY2025 guidance: revenue $78-82M, GAAP EPS $1.55-1.65, non-GAAP EPS $1.71-1.81.
- New Orlando facility on track for mid-2025 completion; ~$5.5M capex remaining in 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025000907/0001558370-25-000907-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000155837025000907/irmd-20250213x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-000907

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer